Patel Naimish Insider Trades

Insider Trading History

Track insider trading activity for Patel Naimish. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Medical Officer
Holding Value $1.11M 22,000 shares
Last Trade
May 29, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.24M 22,000 shares
$56.18
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Medical Officer
Holding Value $977k 19,357 shares
Last Trade
May 29, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$211k 3,786 shares
$55.62
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Medical Officer
Holding Value $1.17M 23,143 shares
Last Trade
May 28, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$564k 10,000 shares
$56.38
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Medical Officer
Holding Value $1.01M 20,000 shares
Last Trade
May 28, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$564k 10,000 shares
$56.38
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Medical Officer
Holding Value $1.94M 38,499 shares
Last Trade
Mar 20, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.17M 68,499 shares
$46.24
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Medical Officer
Holding Value $663k 13,143 shares
Last Trade
Mar 16, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$152k 3,150 shares
$48.26
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Medical Officer
Holding Value $822k 16,293 shares
Last Trade
Mar 14, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$396k 8,125 shares
$48.75
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Medical Officer
Holding Value $1.23M 24,375 shares
Last Trade
Mar 14, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$396k 8,125 shares
$48.75
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Medical Officer
Holding Value $833k 16,500 shares
Last Trade
Oct 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.12M 16,500 shares
$67.74
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Medical Officer
Holding Value $1.26M 25,000 shares
Last Trade
May 30, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$907k 25,000 shares
$36.29
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Medical Officer
Holding Value $306k 6,068 shares
Last Trade
May 29, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$141k 3,932 shares
$35.94
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Medical Officer
Holding Value $505k 10,000 shares
Last Trade
May 28, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$372k 10,000 shares
$37.22
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Medical Officer
Holding Value $1.51M 30,000 shares
Last Trade
May 28, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$372k 10,000 shares
$37.22
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Medical Officer
Holding Value $76.1k 1,508 shares
Last Trade
Apr 03, 2025 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$49.7k 1,508 shares
$32.96
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Medical Officer
Holding Value $2.35M 46,667 shares
Last Trade
Mar 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.97M 46,667 shares
$42.12
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Medical Officer
Holding Value $925k 18,333 shares
Last Trade
Oct 16, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$898k 18,333 shares
$49.00
$50.46
CRISPR Therapeutics AG
CRISPR Therapeutics AG CRSP
Chief Medical Officer
Holding Value $4.29M 85,000 shares
Last Trade
May 28, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.66M 85,000 shares
$54.84
$50.46

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up